SPRYD7 and colorectal carcinoma: At the mRNA level, from analysis of the GSE17538 cohort containing colon and rectum adenocarcinoma samples, high expression of SPRYD7 was significantly associated with the poor survival of CRC patients (p-value = 0.00016, Figure 1D).